UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
UCSF Cardiology
Transforming medicine through innovation and collaboration.
Department of Medicine

Faculty Profiles

Teresa De Marco, MD
M_MED-CARD-CORE
Professor

505 Parnassus Avenue
San Francisco, CA 94143
415-502-8584
Teresa.DeMarco@ucsf.edu

CLINICAL INTERESTS: Advanced heart failure, cardiomyopathies, heart transplantation, mechanical circulatory support, and pulmonary hypertension
RESEARCH INTERESTS: Translational research in the diagnosis, prognosis, medical and surgical treatment for the above disease states

Education and Training

Location Degree or Training Specialty Date
University of California Irvine M.D. School of Medicine 1982

Awards and Honors

2011   Top Doctors, Castle Connolly, 2011
2010   Teresa De Marco, MD, Conference Room, UCSF Cardiovascular Research Institute, 2010
2009   R.H. and Jane G. Logan Endowed Chair in Cardiology, University of California, San Francisco, 2009
2008   Honoree, 500th Thoracic Transplant Celebration, University of California, San Francisco, 2008
2005   Best Cardiologists in the Bay Area, San Francisco Magazine, 2005
2004   Exceptional Physician Award, University of California, San Francisco, 2004
2003   Best Cardiologists in Bay Area, San Francisco Magazine, 2003
2001   Celebrated Faculty Women, University of California, San Francisco, 2001
2001   Best Doctors in America, 2001-2011

Featured Videos

Related Web Sites

Recent Articles (144)

Kallianos K, Brooks GC, Mukai K, Seguro de Carvalho F, Liu J, Naeger DM, De Marco T, Ordovas KG. Cardiac Magnetic Resonance Evaluation of Left Ventricular Myocardial Strain in Pulmonary Hypertension. Acad Radiol. 2017 Aug 30.

Psotka MA, McKee KY, Liu AY, Elia G, De Marco T. Palliative Care in Heart Failure: What triggers specialist consultation? Prog Cardiovasc Dis. 2017 May 05.

Oudiz R, Agarwal M, Rischard F, De Marco T. An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertension. Pulm Circ. 2016 Dec; 6(4):532-538.

Gordon NA, O'Riordan DL, Dracup KA, De Marco T, Pantilat SZ. Let Us Talk About It: Heart Failure Patients' Preferences Toward Discussions about Prognosis, Advance Care Planning, and Spiritual Support. J Palliat Med. 2017 Jan; 20(1):79-83.

Bertero T, Oldham WM, Cottrill KA, Pisano S, Vanderpool RR, Yu Q, Zhao J, Tai Y, Tang Y, Zhang YY, Rehman S, Sugahara M, Qi Z, Gorcsan J, Vargas SO, Saggar R, Saggar R, Wallace WD, Ross DJ, Haley KJ, Waxman AB, Parikh VN, De Marco T, Hsue PY, Morris A, Simon MA, Norris KA, Gaggioli C, Loscalzo J, Fessel J, Chan SY. Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest. 2016 Sep 01; 126(9):3313-35.

Pantilat SZ, O'Riordan DL, Rathfon MA, Dracup KA, De Marco T. Etiology of Pain and Its Association with Quality of Life among Patients with Heart Failure. J Palliat Med. 2016 Dec; 19(12):1254-1259.

Svetlichnaya J, Janmohammed M, De Marco T. Special Situations in Pulmonary Hypertension: Pregnancy and Right Ventricular Failure. Cardiol Clin. 2016 Aug; 34(3):473-87.

Badhwar N, James J, Hoffmayer KS, O'Connell JW, Green D, De Marco T, Botvinick EH. Utility of Equilibrium Radionuclide Angiogram-Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy. J Nucl Med. 2016 Dec; 57(12):1880-1886.

Barnett CF, De Marco T. Treatment of advanced group 2 PH. Prog Cardiovasc Dis. 2016 Jul-Aug; 59(1):78-86.

Thomas RC, Singh A, Cowley P, Myagmar BE, Montgomery MD, Swigart PM, De Marco T, Baker AJ, Simpson PC. A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart. JACC Basic Transl Sci. 2016 Apr; 1(3):155-167.

Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sarrafzadeh M, Tong K, Fonarow GC. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med. 2016 Mar; 176(3):310-8.

Parikh VN, Park J, Nikolic I, Channick R, Yu PB, De Marco T, Hsue PY, Chan SY. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):236-41.

Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016 Mar 21; 37(12):942-54.

Klein L, Greenberg BH, Konstam MA, Gregory D, Kociol RD, Johnson MR, de Marco T. Activities and Compensation of Advanced Heart Failure Specialists: Results of the Heart Failure Society of America (HFSA) Survey. J Card Fail. 2015 Nov; 21(11):924-9.

Johnson CJ, Roberts JD, James JH, Hoffmayer KS, Badhwar N, Ku IA, Zhao S, Naeger DM, Rao RK, O'Connell JW, De Marco T, Botvinick EH, Scheinman MM. Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2015 Jun; 12(6):1268-75.

Howie-Esquivel J, Carroll M, Brinker E, Kao H, Pantilat S, Rago K, De Marco T. A Strategy to Reduce Heart Failure Readmissions and Inpatient Costs. Cardiol Res. 2015 Feb; 6(1):201-208.

Naeger DM, Higgins C, De Marco T, Muzzarelli S, Ordovas KG. Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy. Clin Imaging. 2015 May-Jun; 39(3):432-6.

Deo RC, Musso G, Tasan M, Tang P, Poon A, Yuan C, Felix JF, Vasan RS, Beroukhim R, De Marco T, Kwok PY, MacRae CA, Roth FP. Prioritizing causal disease genes using unbiased genomic features. Genome Biol. 2014 Dec 03; 15(12):534.

Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail. 2015 Jan; 3(1):9-16.

Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. [Pulmonary hypertension due to left heart diseases]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:130-41.

Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéy JL. [Pulmonary hypertension in chronic lung diseases]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:142-52.

Cogswell R, Pritzker M, De Marco T. Performance of the REVEAL pulmonary arterial hypertension prediction model using non-invasive and routinely measured parameters. J Heart Lung Transplant. 2014 Apr; 33(4):382-7.

Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D100-8.

Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D109-16.

Markova SM, De Marco T, Bendjilali N, Kobashigawa EA, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie AE, Khojasteh C, McGlothlin D, Wu AH, Hsueh WC, Witte JS, Schwartz JB, Kroetz DL. Association of CYP2C9*2 with bosentan-induced liver injury. Clin Pharmacol Ther. 2013 Dec; 94(6):678-86.

Cogswell R, McGlothlin D, Kobashigawa E, Shaw R, De Marco T. Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension. J Heart Lung Transplant. 2013 Mar; 32(3):293-8.

Cogswell R, Kobashigawa E, McGlothlin D, Shaw R, De Marco T. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival. J Heart Lung Transplant. 2012 Nov; 31(11):1165-70.

Barnett CF, De Marco T. Pulmonary hypertension associated with left-sided heart disease. Heart Fail Clin. 2012 Jul; 8(3):447-59.

Hong TT, Cogswell R, James CA, Kang G, Pullinger CR, Malloy MJ, Kane JP, Wojciak J, Calkins H, Scheinman MM, Tseng ZH, Ganz P, De Marco T, Judge DP, Shaw RM. Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Jun; 9(6):961-7.

Barnett CF, De Marco T. A chocolate a day keeps the doctor away? J Physiol. 2011 Dec 15; 589(Pt 24):5921-2.

Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE. Secondhand smoke exposure and quality of life in patients with heart failure. Arch Intern Med. 2011 Nov 28; 171(21):1887-93.

Koskenvuo JW, Mirsky R, Zhang Y, Helenius H, Angeli FS, De Marco T, Boyle AJ, Yeghiazarians Y. Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group? Clin Physiol Funct Imaging. 2011 Nov; 31(6):477-84.

Barnett CF, De Marco T. Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria? Chest. 2011 Sep; 140(3):828-829.

Caleshu C, Sakhuja R, Nussbaum RL, Schiller NB, Ursell PC, Eng C, De Marco T, McGlothlin D, Burchard EG, Rame JE. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am J Med Genet A. 2011 Sep; 155A(9):2229-35.

Mirsky R, Jahn S, Koskenvuo JW, Sievers RE, Yim SM, Ritner C, Bernstein HS, Angeli FS, Boyle AJ, De Marco T, Yeghiazarians Y. Treatment of pulmonary arterial hypertension with circulating angiogenic cells. Am J Physiol Lung Cell Mol Physiol. 2011 Jul; 301(1):L12-9.

Chen H, De Marco T, Kobashigawa EA, Katz PP, Chang VW, Blanc PD. Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension. Eur Respir J. 2011 Sep; 38(3):608-16.

McGlothlin D, De Marco T. Transplantation in adults with congenital heart disease. Prog Cardiovasc Dis. 2011 Jan-Feb; 53(4):312-23.

Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria? Barnett CF, De Marco T. Chest. 2011 Sep;140(3):828-9;. Chest. Can pulmonary arterial hypertension be diagnosed by an elevated pulmonary capillary wedge pressure outside of the guideline criteria?. 2011; 3(140):828-9.

Koskenvuo JW, Mirsky R, Zhang Y, Angeli FS, Jahn S, Alastalo TP, Schiller NB, Boyle AJ, Chatterjee K, De Marco T, Yeghiazarians Y. A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model. Int J Cardiovasc Imaging. 2010 Jun; 26(5):509-18.

Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009 Dec; 30(24):3015-26.

Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant. 2009 Oct; 28(10):1081-6.

Jensen BC, Swigart PM, De Marco T, Hoopes C, Simpson PC. {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail. 2009 Nov; 2(6):654-63.

Chen H, Shiboski SC, Golden JA, Gould MK, Hays SR, Hoopes CW, De Marco T. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009 Sep 01; 180(5):468-74.

Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009 Jun; 157(6):1026-34.

McManus D, De Marco T. Pulmonary Hypertension. In Crawford M (ed): Current Diagnosis and Therapy: Cardiology, 3rd Edition, McGraw-Hill/Lange. 2009; 352-70.

Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009; 113(1):12-9.

Boehmer JP, Carlson MD, De Marco T, Jaski BE, Higgins SL, Kennergren C, Epstein AE. Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trials. J Interv Card Electrophysiol. 2008 Nov; 23(2):101-10.

Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008 May 15; 358(20):2117-26.

Chen H, De Marco T, Golden JA, Gould MK. Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion? Chest. 2008 Apr; 133(4):1053-4; author reply 1054.

Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1268-75.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail. 2008 Feb; 14(1):9-18.

Khush KK, Shah SJ, Ristow B, De Marco T, Whooley MA, Schiller NB. Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study. J Am Soc Echocardiogr. 2007 Nov; 20(11):1307-13.

Fix OK, Bass NM, De Marco T, Merriman RB. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl. 2007 Jun; 13(6):875-85.

Elkayam U, Tasissa G, Binanay C, Wagoner L, Gheorghiade M, Warnica JW, Young J, Raybum BK, Rogers J, De Marco T, Leier CV. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart Journal. 2007; (153):99-104.

McGlothlin D, De Marco T. Perioperative Risk Assessment of Pulmonary Arterial Hypertension Patients Undergoing General Surgery. Advances in Pulmonary Hypertension 2007; 6(2):66-73. 2007; 2(6):66-73.

Ghali JK, Boehmer J, Feldman AM, Saxon LS, De Marco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. J Card Fail. Influence of diabetes on cardiac resynchronizaiton therapy with or without defibrillator in patients with advanced heart failure. 2007; 9(13):769-73.

Lindenfeld J, Fledman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, De Marco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Effects of cardiac resynchronization therapy with or without defibrillator on survival and hospitalization in patients with NYHA class IV heart failure. Circulation. 2007; 2(115):204-12.

Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL, Fonarow GC, De Marco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM.. Characterization and prognostic value of persistent hyponatreia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med. 2007.

Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006 Dec 19; 114(25):2766-72.

De Marco T. Pulmonary arterial hypertension and women. Cardiol Rev. 2006 Nov-Dec; 14(6):312-8.

Khush KK, De Marco T, Vakharia KT, Harmon C, Fineman JR, Chatterjee K, Michaels AD. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension. J Card Fail. 2006 Sep; 12(7):507-13.

Galvao M, Kalman J, De Marco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM and the ADHERE Scientific Advisory Committee, Investigators, Coordinators and Study Group. Gender Differences in In-Hospital Management and Outcomes in Patients with Decompensated Heart Failure: Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE). J Cardiac Fail. 2006; 2(12):100-7.

De Marco T. Pulmonary Arterial Hypertension and Women. Cardiology Reviews . 2006; 6(14):312-8.

Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol. 2005 Dec 20; 46(12):2311-21.

Marcus GM, Rose E, Viloria EM, Schafer J, De Marco T, Saxon LA, Foster E. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol. 2005 Dec 20; 46(12):2208-14.

Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006 Jan 03; 47(1):76-84.

Michaels AD, Chatterjee K, De Marco T. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. J Card Fail. 2005 Aug; 11(6):425-31.

Laney AS, De Marco T, Peters JS, Malloy M, Teehankee C, Moore PS, Chang Y. Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension. Chest. 2005 Mar; 127(3):762-7.

8. De Marco T, Rapaport E. Cor pulmonale. In Mason RJ, Broaddus VC, Murray JF, Nadel JA (eds): Murray and Nadel's Textbook of Respiratory Medicine, 4th edition. Philadelphia: Saunders. 2005; 1544-70.

Oka RK, De Marco T, Haskell WL. Effect of treadmill testing and exercise training on self-efficacy in patients with heart failure. Eur J Cardiovasc Nurs . 2005; 3(4):215-9.

Mann MJ, Tseng E, Ratcliffe M, Strattman G, De Silva A, De Marco T, Achorn N, Moskalik W, Hoopes C. Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. J Heart Lung Transplant . 2005; 2(24):222-5.

Frost AE, Langleben D, Oudiz R, Hill N, Horn E, McLaughlin V, Robbins IM, Shapiro S, Tapson VF, Zwicke D, De Marco T, Schilz R, Rubenfire M, Barst RJ. The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol. 2005; 1(43):36-9.

Nath J, De Marco T, Hourigan L, Heidenreich PA, Foster E. . Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients. Echocardiography. 2005; 5(22):374-9.

O’Connell JW, Schreck C, Moles M, Badhwar N, De Marco T, Olgin J, Lee B, Tseng Z, Kumar U, Botvinick EH . A unique method by which to quantitate synchrony with equilibrium radionuclide angiography. J Nucl Cardiol. 2005; 4(12):215-50.

De Marco T, McGlothlin D. Managing Right Ventricular Failure in PAH. Advances in Pulmonary Hypertension. 2005; 4(4):16-26.

Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol. 2004 Nov; 15(11):1284-9.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004 May 20; 350(21):2140-50.

Marcus GM, Michaels AD, De Marco T, McCulloch CE, Chatterjee K. Usefulness of the third heart sound in predicting an elevated level of B-type natriuretic peptide. Am J Cardiol. 2004 May 15; 93(10):1312-3.

Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003 Oct 15; 42(8):1454-9.

Lee SJ, McCulloch C, Mangat I, Foster E, De Marco T, Saxon LA. Isolated bundle branch block and left ventricular dysfunction. J Card Fail. 2003 Apr; 9(2):87-92.

Chatterjee K, De Marco T. Role of nonglycosidic inotropic agents: indications, ethics, and limitations. Med Clin North Am. 2003 Mar; 87(2):391-418.

Choo DC, Huiskes B, Jones J, Fabbri S, Hawkins LA, Chatterjee K, De Marco T, Heywood JT. Amiodarone rescue therapy for severe decompensated heart failure initially unsuitable for beta-blockers. J Cardiovasc Pharmacol Ther 2003 Sep;8(3):187-92.. 2003; 3(8):187-92.

Chatterjee K, De Marco T, Alpert JS. Pulmonary hypertension: hemodynamic diagnosis and management. Arch Intern Med. 2002 Sep 23; 162(17):1925-33.

De Marco T. The MIRACLE trial has merit. J Card Fail. 2002 Aug; 8(4):204-5.

Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation. 2002 Mar 19; 105(11):1304-10.

Saxon LA, De Marco T. Arrhythmias associated with dilated cardiomyopathy. Card Electrophysiol Rev. 2002 Feb; 6(1-2):18-25.

Soran O, Fleishman B, De Marco T, Grossman W, Schneider VM, Manzo K, de Lame PA, Feldman AM. Enhanced External Counterpulsation in Patients With Heart Failure: A Multicenter Feasibility Study. Congest Heart Fail . 2002; 4(8):204-8.

Nanevicz T, Piette J, Zipkin D, Serlin M, Ennis S, De Marco T, Modin G. The feasibility of a telecommunications service in support of outpatient congestive heart failure care in a diverse patient population. Congest Heart Fail. 2000 May-Jun; 6(3):140-145.

Missov E, De Marco T. Cor pulmonale. Cur Treat Options Cardiovasc Med. 2000; (2):149-58.

Oka RK, De Marco T, Haskel WB, Botvinick E, Dae MW, Bolen K, Chatterjee K. Impact of a home-based walking and resistance training program on quality of life in patients with heart failure. Am J Cardiol . 2000; 3(85):365-9.

Kerwin WF, Botvinick EH, O’Connell JW, Merrick SH, De Marco T, Chatterjee K, Scheibly K, Saxon LA. Ventricular contraction abnormalities in dilated cardiomyopathy: Effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol . 2000; 5(35):1221-7.

Schwitter J, De Marco T, Kneifel S, Von Schulthess M, Jorg C, Arheden H, Ruhm S, Stumpf K, Buck A, Parmley WW, Luscher TF, Higgins C. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation. 2000; 23(101):269-72.

Nanevicz T, Piette J, Zipkin D, Serlin M, Ennis S, De Marco T, Modin G. The feasibility of a telecommunication service in support of outpatient congestive heart failure care in a diverse patient population. Congest Heart Fail . 2000; (6):140-5.

Missov E, De Marco T. Cor pulmonale. Current Treatment Options in Cardiovascular Medicine . 2000; (2):149-58.

Schwitter J, De Marco T, Globits S, Sakuma H, Klinski C, Chatterjee K, Parmley WW, Higgins CB. Influence of felodipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: possible interaction with cyclosporine medication. J Heart Lung Transplant. 1999 Oct; 18(10):1003-13.

Missov ED, De Marco T. Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta. 1999 Jun 30; 284(2):175-85.

Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G, Daoud E. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol. 1999 Mar 11; 83(5B):120D-123D.

Missov E, De Marco T. Clinical Insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta . 1999; (284):175-85.

Oka RK, De Marco T, Haskell WL. Perceptions of physical fitness in patients with heart failure. Progress in Cardiovasc Nursing. 1999; 3(14):97-102.

Zellner C, Protter AA, Ko E, Pothireddy R, De Marco T, Hutchison SJ, Chou TM, Chatterjee K, Sudhir K. Coronary vasodilator effects of BNP: Mechanisms of action in coronary conductance and resistance arteries. Am J Physiol . 1999; 45(276):H1049-57.

Schwitter J, De Marco T, Globits T, Sakuma H, Klinski C, Chatterjee K, Parmley WWP, Higgins CB. Influence of fenoldipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: Possible interaction with cyclosporine medication. J Heart Lung Transplant.. 1999; (18):1003-13.

De Marco T, Chatterjee K. Phosphodiesterase inhibitors in refractory heart failure: Bridge to ß-blockade? J Am Coll Cardiol.. 1998; 6(31):1341-3.

De Marco T, Parmley WW. ß-adrenergic blockers in the management of heart failure. Western J Med . 1998; 6(168):531.

Globits S, De Marco T, Schwitter J, Sakuma H, O'Sullivan M, Rifkin C, Keith F, Chatterjee K, Parmley WW, Higgins CB. Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging: potential mechanisms. J Heart Lung Transplant. 1997 May; 16(5):504-10.

De Marco T, Damon LE, Colombe B, Keith F, Chatterjee K, Garovoy MR. Successful immunomodulation with intravenous gamma globulin and cyclophosphamide in an alloimmunized heart transplant recipient. J Heart Lung Transplant. 1997 Mar; 16(3):360-5.

De Marco T, Goldman L. Predicting outcomes in severe heart failure. Editorial. Circulation . 1997; 12(95):2597-9.

Shinbane JS, Chu E, De Marco T, Sobol Y, Fitzpatrick AP, Lau DM, Klinski C, Schiller J, Griffin JC, Chatterjee KC. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol . 1997; (30):1295-1300.

Chatterjee K, De Marco T. Management of Refractory Heart Failure. In Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS (eds): Heart Failure Scientific Principles and Clinical Practice. New York, NY, Churchill Livingstone Inc. 1997; 853-73.

Chou T, Sudhir K, Amidon T, Klinski C, De Marco T, Chatterjee K, Botvinick EH. Adenosine produces greater coronary hyperemic response in heart transplant recipients in comparison to dipyridamole. Am J Cardiol . 1996; (78):908-13.

De Marco T, Chatterjee, K. Refractory heart failure: A therapeutic approach. J Intensive Care Med . 1996; (11):121-48.

De Marco T, Dae M, Yuen-Green MS, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol. 1995 Mar 15; 25(4):927-31.

Sudhir K, De Marco T, Kumar S, Maganti K, Amidon TM, de Groot CJ, Klinski C, Lau D, Keith F, Taylor RN, et al. Transcoronary and pulmonary vascular dynamics of endothelin-1 in cardiac transplant recipients. J Heart Lung Transplant . 1995; 2(14):230-6.

Barbant SD, Redberg RF, Tucker KJ, Chatterjee K, De Marco T, Foster E, Schiller NB. Abnormal pulmonary artery pressure profile after cardiac transplantation: An exercise Doppler echocardiographic study. Am Heart J. 1995; 6(129):1185-92.

Chatterjee K, De Marco T. Treatment of Symptomatic Heart Failure In Dhalla NS, Beamish RE, Takeda N, Nagano M (eds): The Failing Heart. New York, NY, Raven Press, Ltd. . 1995; 337-53.

Bersin RM, Wolfe C, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, Henderson GN, de Marco T, Chatterjee K. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol. 1994 Jun; 23(7):1617-24.

Chatterjee K, Wolfe CL, De Marco T. Non-glycoside inotropes in congestive heart failure. Are they beneficial or harmful? Clinics of North America . 1994.

Sudhir K, MacGregor JS, De Marco T, De Groot CJM, Taylor RN, Chou TM, Yock PG, Chatterjee K. Cyclosporin impairs release of endothelin derived relaxing factor in epicardial and resistance coronary arteries. Circulation . 1994; 3018-23(90).

De Marco T, Keith F. Bridge to Cardiac Transplantation In Parmley WW, Chatterjee K, (eds): Cardiology. Philadelphia JB Lippincott Publishing Co., . 1994; 7(3):1-21.

Cavero PG, Sudhir K, Galli F, De Marco T, Keith F, Chatterjee K. Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: Influence of cyclosporine therapy. Am Heart J . 1994; 6(127):1581-7.

Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, De Marco T. Cyclosporine induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transplant . 1993; (12):440-4.

Tucker K, Redberg R, Ploss D, De Marco T, Foster E, Schiller N. Noninvasive assessment of the pulmonary artery pressure response to exercise after uncomplicated heart transplantation. J Heart Lung Transplant 1993. 1993; (12):604-12.

Bersin RM, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, De Marco T, Wolfe CL, Chatterjee K. Importance of oxygen-hemoglobin binding to oxygen transport in congestive heart failure. British Heart J . 1993; (70):443-7.

Cavero PG, De Marco T, Kwasman M, Lau D, Liu M, Chatterjee K. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure. J Am Coll Cardiol. 1992 Dec; 20(7):1542-8.

Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, Yuen-Green MS. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies. J Nucl Med. 1992 Aug; 33(8):1444-50.

De Marco T, Deedwania P, Chatterjee K. Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function. Am J Cardiol. 1992 Apr 09; 69(11):31D-36D.

White M, Rouleau J-L, Ruddy TD, De Marco T, Moher D, Chatterjee K. Decreased coronary sinus oxygen content: A predictor of adverse prognosis in patients with severe heart failure. J Am Coll Cardiol . 1991; (18):1631-7.

Truit LC, Denaro CP, Lake JR, De Marco T. MR imaging of reversible cyclosporine-A neurotoxicity. AJNR . 1991; (12):651-9.

Hosenpud JD, De Marco T, Frazier OH, Griffith BP, Menkins AH, O'Connell JB, Olivari MT, Valentine HA. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation . 1991; (supp III):338-43.

Sudhir K, Fitzgerald P, MacGregor JA, De Marco T, Chatterjee K, Yock P. Transvenous coronary ultrasound imaging: A novel approach to visualization of the coronary arteries. Circulation . 1991; (84):1957-61.

Chatterjee K, De Marco T. Systemic and coronary hemodynamics and pharmacodynamics of enalapril and enalaprilat in congestive heart failure. Drugs . 1990; 4(39):29-40.

Chatterjee K, De Marco T. Systemic and coronary haemodynamics and pharmacodynamics of enalapril and enalaprilat in congestive heart failure. Drugs. 1990; 39 Suppl 4:29-40; discussion 41-2.

Chatterjee K, De Marco T. Central and peripheral adrenergic receptor agonists in heart failure. Eur Heart J. 1989 Jun; 10 Suppl B:55-63.

De Marco T, Daly PA, Chatterjee K. Systemic and coronary hemodynamic and neurohumoral effects of levodopa in chronic congestive heart failure. Am J Cardiol. 1988 Dec 01; 62(17):1228-33.

De Marco T, Kwasman M, Lau D, Chatterjee K. Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost. Am J Cardiol. 1988 Aug 11; 62(5):57C-62C.

Chatterjee K, De Marco T, Rouleau JL. Vasodilator therapy in chronic congestive heart failure. Am J Cardiol. 1988 Jul 11; 62(2):46A-54A.

De Marco T, Chatterjee K, Rouleau JL, Parmley WW. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J. 1988 Apr; 115(4):809-15.

Stein MG, De Marco T, Gamsu G, Finkbeiner W, Golden JA. Computed tomography: Pathologic correlation in lung disease due to tocainide. Am Rev Respr Dis 1988; 137:458-60. 1988; (137):458-60.

Chatterjee K, De Marco T, Rouleau J-L. Vasodilator therapy in chronic congestive heart failure. Am J Cardiol 1988; 62:46A-54A.. 1988; (62):46A-54A.

De Marco T, Chatterjee K. A patient with fatigue and jugular venous distention. The Complicated Cardiovascular Patient. 1987; 3(1):9-12.

De Marco T, Daly PA, Liu M, Kayser S, Parmley WW, Chatterjee K. Enalaprilat: A new parental angiotensin-converting enzyme inhibitor: Rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol 1987; 9:1131-38. 1987; (9):1131-8.

De Marco T, Chatterjee K. A patient with refractory congestive heart failure. The Complicated Cardivascular Patient. 1987; 1(2):20-31. 1987; 2(1):20-31.

Axelrod RD, De Marco T, Dae M, Botvinick EH, Chatterjee K. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure. J Am Coll Cardiol 1987; 9:1124-30. 1987; (9):1124-30.

Hansen RM, Viquerat C, Wiener-Kronish JP, De Marco T, Bahtia S, Marks JD, Botvinick EH, Chatterjee K, Matthay. Poor correlation between pulmonary arterial wedge pressure and left ventricular end-diastolic volume after coronary artery bypass graft surgery. Anesthesiology 1986; 64(6):764-70. 1986; 6(64):764-70.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.